SCHEMBL10195660

SCHEMBL10195660

CC1(C)OC(C)(C)C(O)=C(c2cc(Oc3nc4ccc([N+](=O)[O-])cc4s3)ccc2C2CC2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.37
HTT P42858 2/20 0.37
SNCA P37840 1/20 0.36
RAB9A P51151 3/20 0.36
ALDH1A1 P00352 4/20 0.36
NPC1 O15118 2/20 0.36
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
PTPN11 Q06124 1/20 0.36
DYRK1A Q13627 1/20 0.35
APP P05067 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PDK1 Q15118 1/20 0.34
KMT2A Q03164 5/20 0.34
MAPT P10636 5/20 0.34
MEN1 O00255 4/20 0.34
LMNA P02545 1/20 0.34
NOD2 Q9HC29 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10195662 0.89 MAPT (0.37) SMN1; SMN2HTTRAB9AALDH1A1NPC1
SCHEMBL10195645 0.88 CASP3 (0.33) SMN1; SMN2RAB9AALDH1A1NPC1DYRK1A
SCHEMBL10195642 0.87 CYP1A2 (0.40) SMN1; SMN2CYP3A4
SCHEMBL16351646 0.86 KMT2A (0.39) SMN1; SMN2HTTSNCARAB9AALDH1A1
SCHEMBL10195655 0.86 EPHX2 (0.38) DYRK1AMAPTRIPK1RIPK3
SCHEMBL10195650 0.83 NPC1 (0.34) RAB9ANPC1
SCHEMBL10195665 0.79 CTSD (0.32) SMN1; SMN2RAB9AMAPT
SCHEMBL10195635 0.77 DNMT3B (0.33) HTTCYP3A4TSHRTDP1KMT2A
SCHEMBL10195291 0.74 EPHX2 (0.34) SMN1; SMN2RAB9AALDH1A1NPC1DYRK1A
SCHEMBL10195359 0.74 ATAD2 (0.38) SMN1; SMN2HTTRAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 SMN1; SMN2 2218/4885HTT 414/4885SNCA 4424/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 SMN1; SMN2 2952/4885HTT 584/4885SNCA 4714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.